Drugs / Control Quadrivalent influenza virus vaccine
Control Quadrivalent influenza virus vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT05431725 Comparator | Jul 2022 → Jul 2023 | influenza | Sinovac Biotech Co., Ltd | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Control Quadrivalent influenza virus vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05431725 ↗ |
| Modality | Vaccine | “The Control Quadrivalent influenza virus vaccines are manufactured by Sanofi” NCT05431725 ↗ |
| Route | Intramuscular | “The routine of administration is intramuscular injection into deltoid region.” NCT05431725 ↗ |